<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03049293</url>
  </required_header>
  <id_info>
    <org_study_id>1610-ABU-074-HF</org_study_id>
    <nct_id>NCT03049293</nct_id>
  </id_info>
  <brief_title>Measurement of Midazolam Levels in Follicular Fluid</brief_title>
  <official_title>Measurement of Midazolam Levels in Follicular Fluid and Correlation of Midazolam Levels in Follicular Fluid and Oocyte Quality, Fertilization Rate, Embryo Development Pattern and Euploid Status</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ART Fertility Clinics LLC</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>ART Fertility Clinics LLC</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine the impact of Midazolam levels in follicular fluid on morpho-kinetics and&#xD;
      morpho-genetics.&#xD;
&#xD;
      The reason to measure Midazolam levels in larger size follicles in this study is to maximize&#xD;
      the chances to get a mature oocyte and therefore develop into a potential embryo to be&#xD;
      analyzed.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The correlation of Midazolam levels in follicular fluid and euploid status of the embryos is&#xD;
      worth exploring as no data exists that suggests any influence on the quality of the embryos&#xD;
      from using this substance for IVF since its earliest days. Measuring time lapsed from&#xD;
      injection to first oocyte retrieval as well as time lapsed in between first and last oocyte&#xD;
      retrieved will grand insight into the rise of levels of Midazolam inside the follicular&#xD;
      fluid, correlated with the chromosomal status and the morphokinetic development of the&#xD;
      euploid embryos.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Difficulty in recruiting participants&#xD;
  </why_stopped>
  <start_date type="Actual">June 20, 2017</start_date>
  <completion_date type="Actual">October 1, 2019</completion_date>
  <primary_completion_date type="Actual">October 1, 2019</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Midazolam values measured by the time from the injection of Midazolam to the oocyte aspiration .</measure>
    <time_frame>6-12 months</time_frame>
    <description>To determine the impact of Midazolam levels in follicular fluid on morpho-kinetics and morpho-genetics.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Midazolam Overdose</condition>
  <arm_group>
    <arm_group_label>Control group using Propofol</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Sedation will be established by administering 100mcs of Fentanyl, and 1-1.5mg/kg of body weight of Propofol.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Study group Midazolam group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sedation will be established by administering Midazolam 1mg, 100mcs of Fentanyl, and 0.5-1mg/kg of body weight of Propofol. Further boluses of Propofol will be given according to the need of the patient and time consumed for oocyte retrieval.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Midazolam</intervention_name>
    <description>The impact of Midazolam levels in follicular fluid.</description>
    <arm_group_label>Study group Midazolam group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Infertility (prim. / sec.)&#xD;
&#xD;
          -  Age &gt;18 - ≤ 38 years.&#xD;
&#xD;
          -  BMI 19-30&#xD;
&#xD;
          -  Stimulation in GnRH-antagonist protocol, using rFSH&#xD;
&#xD;
          -  Expected normal ovarian response (6)&#xD;
&#xD;
          -  At least 4 follicles with the size ≥ than 17 mm on the day of OPU&#xD;
&#xD;
          -  Patients undergoing PGS&#xD;
&#xD;
          -  Able to understand the aim of the study and to provide consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History of endometriosis, classified according to the American Fertility Society (AFS)&#xD;
             as stage 3 or more.&#xD;
&#xD;
          -  Severe male factor&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>38 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Human Mo Fatemi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>IVI Middle East Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>IVI Middle East Fertilty Clinic</name>
      <address>
        <city>Abu Dhabi</city>
        <country>United Arab Emirates</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Arab Emirates</country>
  </location_countries>
  <link>
    <url>https://www.ncbi.nlm.nih.gov/pubmed/7589618</url>
    <description>Follicular fluid levels of midazolam, fentanyl, and alfentanil during transvaginal oocyte retrieval.</description>
  </link>
  <link>
    <url>https://www.ncbi.nlm.nih.gov/pubmed/10402383</url>
    <description>Midazolam/ketamine sedative combination compared with fentanyl/propofol/isoflurane anaesthesia for oocyte retrieval.</description>
  </link>
  <link>
    <url>http://www.sciencedirect.com/science/article/pii/S0952818001003312</url>
    <description>General anesthesia versus monitored anesthesia care with remifentanil for assisted reproductive technologies: effect on pregnancy rate</description>
  </link>
  <link>
    <url>http://humupd.oxfordjournals.org/content/20/1/124.long</url>
    <description>Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice</description>
  </link>
  <link>
    <url>http://www.sciencedirect.com/science/article/pii/S0015028210026877</url>
    <description>Age-specific serum anti-Müllerian hormone values for 17,120 women presenting to fertility centers within the United States</description>
  </link>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>January 12, 2017</study_first_submitted>
  <study_first_submitted_qc>February 9, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">February 10, 2017</study_first_posted>
  <last_update_submitted>May 2, 2021</last_update_submitted>
  <last_update_submitted_qc>May 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>ART Fertility Clinics LLC</investigator_affiliation>
    <investigator_full_name>Prof Dr. Human Fatemi</investigator_full_name>
    <investigator_title>Medical Director</investigator_title>
  </responsible_party>
  <keyword>COPD,IVF</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Drug Overdose</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Midazolam</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

